Search Results

Filter
  • 1-10 of  1,568 results for ""Artemisinins""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum.

  • Authors : Duffey M; Department of Infectious Diseases, Parasitology, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 324, 69120, Heidelberg, Germany.; German Center for Infection Research (DZIF), Partner Site Heidelberg, 69120, Heidelberg, Germany.

Subjects: Antimalarials/Antimalarials/Antimalarials/*pharmacology ; Artemisinins/Artemisinins/Artemisinins/*pharmacology ; Carbanilides/Carbanilides/Carbanilides/*pharmacology

  • Source: Malaria journal [Malar J] 2018 Mar 20; Vol. 17 (1), pp. 121. Date of Electronic Publication: 2018 Mar 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.

  • Authors : Lingani M; Institut de Recherche en Sciences de la Santé/Direction Régionale du Centre Ouest (IRSS/DRCO), Nanoro, Burkina Faso. .; Unité de Recherche Clinique de Nanoro (URCN), Nanoro, Burkina Faso. .

Subjects: Amodiaquine/Amodiaquine/Amodiaquine/*therapeutic use ; Artemether, Lumefantrine Drug Combination/Artemether, Lumefantrine Drug Combination/Artemether, Lumefantrine Drug Combination/*therapeutic use ; Artemisinins/Artemisinins/Artemisinins/*therapeutic use

  • Source: Malaria journal [Malar J] 2020 Jan 06; Vol. 19 (1), pp. 8. Date of Electronic Publication: 2020 Jan 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.

  • Authors : Byakika-Kibwika P; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda. .; Infectious Diseases Institute, Kampala, Uganda. .

Subjects: Antimalarials/Antimalarials/Antimalarials/*therapeutic use ; Artemisinins/Artemisinins/Artemisinins/*therapeutic use ; Artesunate/Artesunate/Artesunate/*therapeutic use

  • Source: BMC infectious diseases [BMC Infect Dis] 2019 Dec 03; Vol. 19 (1), pp. 1025. Date of Electronic Publication: 2019 Dec 03.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against.

  • Authors : Krishna S; Centre for Diagnostics and Antimicrobial Resistance, Institute for Infection & Immunity, St. George's, University of London, London, UK. .; St George's University Hospitals NHS Foundation Trust, London, UK. .

Subjects: Drug Resistance*; Antimalarials/Antimalarials/Antimalarials/*chemistry ; Artemisinins/Artemisinins/Artemisinins/*therapeutic use

  • Source: Malaria journal [Malar J] 2019 Oct 03; Vol. 18 (1), pp. 339. Date of Electronic Publication: 2019 Oct 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine.

  • Authors : Daher A; Institute of Drug Technology (Farmanguinhos), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil. .; Vice-presidency of Research and Biological Collections, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil. .

Subjects: Antimalarials/Antimalarials/Antimalarials/*pharmacology ; Artemisinins/Artemisinins/Artemisinins/*pharmacology ; Chloroquine/Chloroquine/Chloroquine/*pharmacology

  • Source: Malaria journal [Malar J] 2019 Sep 23; Vol. 18 (1), pp. 325. Date of Electronic Publication: 2019 Sep 23.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.

  • Authors : Moradin N; Department of Biochemistry, McGill University, 3649 Promenade Sir William Osler, room 366, Montreal, QC, H3G 0B1, Canada.; Torre S

Subjects: Drug Synergism*; Antimalarials/Antimalarials/Antimalarials/*administration & dosage ; Artemisinins/Artemisinins/Artemisinins/*administration & dosage

  • Source: Malaria journal [Malar J] 2016 May 06; Vol. 15 (1), pp. 260. Date of Electronic Publication: 2016 May 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Household characteristics as predictors of access to paediatric malaria treatment in Homa-Bay County, Kenya.

  • Authors : Kodhiambo MO; School of Pharmacy, Kenyatta University, P.O. Box 43844-00100, Nairobi, Kenya. .; Amugune BK

Subjects: Analgesics/Analgesics/Analgesics/*economics ; Antimalarials/Antimalarials/Antimalarials/*economics ; Artemisinins/Artemisinins/Artemisinins/*economics

  • Source: BMC research notes [BMC Res Notes] 2019 Aug 07; Vol. 12 (1), pp. 490. Date of Electronic Publication: 2019 Aug 07.Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.

  • Authors : Tyagi RK; The Vac4All Initiative, 26 Rue Lecourbe, 75015, Paris, France.; Biomedical Parasitology Unit, Institut Pasteur, Paris, France.

Subjects: Antimalarials/Antimalarials/Antimalarials/*therapeutic use ; Artemisinins/Artemisinins/Artemisinins/*therapeutic use ; Artesunate/Artesunate/Artesunate/*therapeutic use

  • Source: BMC medicine [BMC Med] 2018 Oct 01; Vol. 16 (1), pp. 181. Date of Electronic Publication: 2018 Oct 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Plasmodium falciparum: multifaceted resistance to artemisinins.

  • Authors : Paloque L; CNRS, LCC (Laboratoire de Chimie de Coordination) UPR8241, 205 route de Narbonne, BP 44099, 31077, Toulouse Cedex 4, France. .; Université de Toulouse, UPS, INPT, 31077, Toulouse Cedex 4, France. .

Subjects: Drug Resistance*/Drug Resistance*/Drug Resistance*/drug effects ; Drug Resistance*/Drug Resistance*/Drug Resistance*/genetics ; Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/drug effects

  • Source: Malaria journal [Malar J] 2016 Mar 09; Vol. 15, pp. 149. Date of Electronic Publication: 2016 Mar 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Synergistic anti-malarial action of cryptolepine and artemisinins.

  • Authors : Forkuo AD; Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. .; Ansah C

Subjects: Antimalarials/Antimalarials/Antimalarials/*therapeutic use ; Malaria/Malaria/Malaria/*drug therapy; Animals

  • Source: Malaria journal [Malar J] 2016 Feb 16; Vol. 15, pp. 89. Date of Electronic Publication: 2016 Feb 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium:

Record details

×
  • 1-10 of  1,568 results for ""Artemisinins""